How Is Penile Cancer Diagnosed? Tests, Biopsy, and Staging Explained

Most men come to a penile cancer diagnosis the same way. You notice something on your penis that does not go away. Maybe it is a sore, a lump, a red patch, a wart-like growth, a change in skin color, or a discharge under the foreskin. You wait a while, hoping it clears up. When it does not, you see a doctor. Many of these changes turn out to be an infection or a harmless skin condition, and many penile cancer symptoms look almost exactly like ordinary skin problems. That is exactly why testing matters. Only a lab test can tell the difference.

The path from noticing a change to getting an answer usually has three steps.

1. A doctor looks at the area and asks about your health.

2. A small piece of tissue is removed and sent to a lab.

3. If cancer is found, more tests check whether it has spread.

Each step gives your care team a little more information, and together they build the full picture that guides treatment.

Several kinds of doctors may be involved. Your family doctor or a walk-in clinic doctor often sees you first and then refers you on.

• A urologist (a surgeon who specializes in the urinary tract and male reproductive organs) usually leads the workup and does the biopsy.

• A dermatologist (a skin specialist) may be involved when the change looks like a rash, a white patch, or a skin condition rather than a tumor.

• A pathologist (a doctor who examines tissue and cells under a microscope) is the one who actually makes the diagnosis by studying the tissue that was removed.

• A radiologist reads any scans.

• A nuclear medicine specialist may help map the lymph nodes.

Penile cancer is rare, at roughly 0.5 cases per 100,000 men each year in the United States, and doctors who treat it are used to talking about genitals, hygiene, foreskins, and sex in a plain and practical way. Delay is the real danger here, not the conversation. Penile cancer found early is often highly curable.

What Tests Are Used to Diagnose Penile Cancer?

There is no single test for penile cancer. Instead, your doctor works through a sequence, starting with the simplest and least invasive steps. Some men need only an exam and a small biopsy. Others need lymph node procedures and scans. How far the testing goes depends on what the earlier results show.

It helps to know that the tests answer two different questions.

1. Is this cancer? That question is answered only by a biopsy.

2. How far has it gone? That question is answered by examining the groin lymph nodes and, in some cases, by imaging scans.

Both questions matter, because treatment for a shallow surface cancer is very different from treatment for cancer that has reached the lymph nodes.

Physical Exam and Medical History

Your first appointment usually starts with questions. Your doctor will ask when you first noticed the change, whether it has grown, whether it hurts or bleeds, whether there is any discharge or smell, and whether anything has made it better or worse. Be as specific as you can. Bringing a note or a phone photo showing when you first saw the change is useful.

Your doctor will also ask about things that raise the odds of penile cancer. That list usually includes whether you were circumcised (had the foreskin removed), whether you have trouble pulling the foreskin back, any history of long lasting inflammation of the penis, any past infection with HPV (human papillomavirus, a very common virus spread by skin to skin sexual contact), any history of HIV or another condition that weakens the immune system, smoking, and any past treatment with light therapy for a skin condition. You can read more in our guide to risk factors for penile cancer. These questions are not there to judge you. They are there because the answers change what the doctor looks for.

Then comes the exam itself. Your doctor will look at and gently feel the whole penis, including the shaft, the head (glans), and the opening of the urethra. If you are not circumcised, the doctor will pull the foreskin back and check underneath, because tumors often start on the inner foreskin or the glans and can hide completely under a tight foreskin. The doctor will note the size of the area, exactly where it sits, whether it is flat or raised or ulcerated, and how deeply it seems to go. Doctors also look for more than one spot, since penile cancer can appear in more than one place at the same time. The nearby skin, the scrotum, and the area around the anus are usually checked too.

An important part of the exam is your groin. Your doctor will press firmly along both sides of the groin, feeling for the inguinal lymph nodes (small filtering glands in the groin crease that catch fluid draining from the penis). Penile cancer spreads in an orderly way. It goes to the groin nodes first, then to nodes deeper in the pelvis, and only then to distant places. That is why the groin exam is not a formality. Your doctor notes how many nodes feel enlarged, which side they are on, how big they are, and whether they move freely or feel stuck in place.

Two things about the groin exam are worth understanding.

1. Swollen nodes do not always mean cancer, because an infection can make nearby nodes swell as a normal immune reaction.

2. A normal groin exam does not fully rule out spread. Around 20% to 25% of men whose groin nodes feel completely normal still have tiny deposits of cancer hiding inside those nodes. Feeling the nodes is also harder if you carry extra weight or have had past groin surgery. This is the single biggest reason the workup often continues even when the exam looks reassuring.

Biopsy: The Only Way to Confirm Penile Cancer

A biopsy is the removal of tissue so a pathologist can look at it under a microscope. This is the only way to know for certain whether an abnormal area is cancer. No scan, no blood test, and no physical exam can confirm penile cancer on its own. Results usually come back in a few days, though special stains can take longer.

Biopsies are done with local anesthesia (numbing medicine injected into the area) in a clinic or day surgery unit, or sometimes under general anesthesia while you are asleep. The site may need a stitch or two afterward. You will usually be told how to keep the area clean and when you can return to normal activity. It is normal to feel anxious about a procedure in this part of your body. Tell your care team if you would like more numbing medicine or a sedative, and ask them to explain each step as they go.

There are several ways to take the sample, and the choice depends on how big the area is, how deep it seems, and where it sits:

• Punch biopsy: The doctor presses a small round cutting tool, a bit like a tiny cookie cutter, through all the layers of the skin and lifts out a plug of tissue. A punch of about 2 to 3 millimeters taken under local anesthesia is often enough to confirm the diagnosis. Punch biopsies are quick and leave a very small wound.

• Incisional biopsy: The doctor uses a scalpel to cut out a small piece of the abnormal area while leaving the rest in place. This is preferred for larger areas, ulcerated areas where the top layer of skin is missing, and any area that may have grown deep into the penis, because the sample can be taken deep enough to show how far down the cancer reaches.

• Excisional biopsy: The doctor removes the entire abnormal area. This works well when the spot is small, such as a lump or a raised flat patch, and can be taken out without changing the shape or function of the penis. An excisional biopsy can serve as both the diagnosis and the treatment of a very small cancer.

• Circumcision as the biopsy: When the abnormal area sits on the foreskin or only under the foreskin, removing the foreskin can be the cleanest way to get the tissue. The foreskin comes out in one piece with the lesion inside it, and the whole specimen goes to the lab. For a small foreskin cancer, that one operation may be both the biopsy and the full treatment. Pathologists ask surgeons to pin circumcision specimens flat so the edges can be measured accurately.

Depth matters, and this is where sample size comes in. In one series, when biopsies averaged only 1 millimeter, pathologists could not judge how deep the cancer had grown in 91% of cases, and they could see cancer inside small blood or lymph vessels in only 9% to 11% of cases. So if your doctor needs to know the depth in order to plan surgery, a deeper incisional biopsy is preferred over a shallow scrape. If your first biopsy comes back inconclusive, a repeat or deeper biopsy is a normal next step rather than a sign that something went wrong.

A biopsy before treatment is recommended whenever the diagnosis is not obvious by eye, and also whenever nonsurgical treatment such as a skin cream, laser, or radiation is being considered, because those treatments need tissue proof first. Even when a tumor looks unmistakable, the biopsy details still help decide whether your lymph nodes need to be checked surgically.

Understanding Your Pathology Report

Your pathology report is the document that turns "we found something" into a real plan. It can look like a wall of technical language, so it helps to know what each part means. You are entitled to a copy, and asking for one is a good idea.

Cell type comes first. More than 95% of penile cancers are squamous cell carcinoma, which means the cancer started in the flat surface cells that line the skin of the penis and the inner foreskin. Within that group are subtypes with different behavior.

• HPV independent types, such as usual, verrucous, papillary, and sarcomatoid.

• HPV associated types, such as basaloid and warty.

Some subtypes almost never spread. Verrucous carcinoma, for example, makes up roughly 3% to 8% of cases and has no reported spread to other organs. Others, such as sarcomatoid carcinoma, are much more aggressive. Rarer non-squamous cancers of the penis include melanoma, sarcoma, and lymphoma.

Grade describes how abnormal the cells look. Grade 1 cells still resemble normal cells and are called well differentiated. Grade 3 cells look very abnormal and are called poorly differentiated, as is the sarcomatoid pattern. Higher grade tumors are more likely to spread to lymph nodes. It is worth knowing that grading is somewhat subjective, and agreement between pathologists on penile cancer grade has been measured as poor to moderate. The grade on a small biopsy can also differ from the grade on the larger specimen removed at surgery. This is one reason a second pathology opinion can be valuable.

Depth of invasion is measured in millimeters, from the surface layer down to the deepest cancer cell. Along with this, the report lists which structures the cancer has reached, such as the loose tissue just under the skin, the spongy erectile tissue (corpus spongiosum), the main erectile chambers (corpora cavernosa), or the urethra. This is the single biggest driver of the T part of the stage, and it decides whether surgery can be organ-sparing.

Lymphovascular invasion means cancer cells were seen inside small lymph channels or blood vessels within the tumor.

Perineural invasion means cancer cells were seen wrapped around nerves. Both are warning signs that cells have found a route out of the tumor, and both push you into a higher risk group for hidden lymph node spread.

Together with stage and grade, they are how your team decides whether to check your lymph nodes surgically. A grade 1 surface tumor with no lymphovascular or perineural invasion is considered low risk, and the chance of node spread is too small to justify node surgery. Once a tumor reaches stage T1b or above, the risk climbs enough that guidelines strongly recommend surgical node staging. In the middle sits stage T1a grade 2 disease, where the risk of hidden node disease is about 6% to 8%, and the decision is made individually.

Margins describe the edge of the removed tissue. A clear or negative margin means normal tissue surrounds the cancer on all sides. A positive margin means cancer reaches the cut edge, and more tissue may need to be removed. The report gives the margin distance in millimeters.

p16 and HPV testing are done on the same tissue. p16 is a protein that builds up inside cells when a high-risk HPV infection is driving the cancer, so staining the tissue for p16 acts as a stand-in test for HPV. Overall, about 41.6% of penile cancers stain positive for p16, and the rate is much higher in HPV associated subtypes at around 85.8% compared with about 17.1% in HPV independent subtypes. Knowing your p16 status matters because p16 positive tumors have tended to do better, with five-year disease-specific survival near 88% for p16 positive tumors compared with about 58% for p16 negative tumors in one analysis.

Sentinel Lymph Node Biopsy and Dynamic Sentinel Node Biopsy

Because so many men with normal-feeling groins still have hidden cancer in their nodes, and because waiting until nodes become obvious leads to worse outcomes, doctors need a way to check the nodes without removing all of them. That method is sentinel lymph node biopsy.

A sentinel lymph node is the first node that fluid from the tumor drains into. The logic is simple. If cancer cells left the tumor through the lymph system, that first node is where they would land first. If the first node is clean, the rest of that group is very likely clean too. To find it, a surgeon injects a small amount of a radioactive tracer, a blue dye, or both near the tumor. The material travels along the same lymph channels the cancer would use. The surgeon then finds the node with a handheld detector or by looking for the blue staining, makes a small cut in the skin over it, and removes it. A pathologist checks it for cancer cells. It may be done as an outpatient procedure or with a short hospital stay.

For penile cancer specifically, the version used is called dynamic sentinel node biopsy, often shortened to DSNB. "Dynamic" refers to the imaging done before and during surgery to map where the fluid actually drains in your body, which can differ from person to person and can involve nodes on both sides. It typically combines a radioactive tracer with patent blue dye, and newer versions add detailed scanning that layers the tracer picture over a CT image, or use tracers that are both radioactive and glow under special light. Penile cancer specimens from sentinel nodes are examined with a standard staining protocol designed to catch very small deposits.

If a sentinel node contains cancer, the standard next step is to remove the remaining nodes on that side of the groin. If the sentinel nodes are clear, you can usually avoid the larger operation entirely, which spares you a great deal of swelling and wound trouble. Where dynamic sentinel node biopsy is not available and travelling to a center that offers it is not possible, a more limited lymph node dissection may be offered instead.

Fine Needle Aspiration and Inguinal Lymph Node Dissection

When a groin node can be felt or looks abnormal on an ultrasound, the fastest way to check it is a fine needle aspiration, or FNA. The doctor numbs the skin, slides a thin hollow needle into the node, and pulls back on a syringe to draw out cells and a few drops of fluid. Those cells go to the lab. It takes only a few minutes and can be done in a clinic. If the node is too deep to feel, an ultrasound or CT scan is used to guide the needle to the right spot. FNA is used on lymph nodes, not on the penis itself, where a tissue biopsy is needed instead.

FNA works best as a way to confirm cancer rather than to rule it out. When ultrasound plus FNA is used before sentinel node surgery in men whose groins feel normal, it correctly finds node cancer only about 39% of the time, but when it is positive, it is right essentially every time. So a negative result does not let you skip the surgical check, while a positive result saves you a step and lets treatment start sooner. Because of that, guidelines recommend an inguinal ultrasound with FNA of any suspicious node before a planned dynamic sentinel node biopsy. When a node is clearly abnormal on exam, an image-guided biopsy to confirm cancer is strongly recommended before treatment begins.

Inguinal lymph node dissection, or ILND, is surgery to remove the lymph nodes from one or both sides of the groin. It is the most accurate way to know what is in the nodes, and it is also treatment when cancer is already there. Nodes with a palpable lump turn out to contain cancer in roughly 45% to 80% of cases, so removing them is often necessary rather than precautionary. The tissue is examined for how many nodes are involved, the size of the largest cancer deposit, and whether cancer has broken through the outer capsule of a node, which is called extranodal or extracapsular extension. Even a single node with extracapsular extension changes the stage.

The trade-off with ILND is side effects. Standard full dissection carries the highest complication rate of any staging option here. Surgeons developed a modified template that uses a shorter cut, stays within a smaller area, and preserves a major leg vein, but even that version has complication rates in the range of 35% to 49% and misses disease in 15% to 20% of cases. Newer approaches use a camera through small incisions, sometimes with robotic assistance, which mainly reduces wound problems. Swelling of the leg or groin, called lymphedema (fluid buildup when lymph channels are cut), remains a real risk and is closely tied to how many nodes are removed. Other possible effects include a fluid collection under the skin, numbness, infection, and slow wound healing. This is exactly why so much effort goes into sentinel node techniques that let men with clear nodes avoid the bigger operation.

Imaging Tests: Ultrasound, MRI, CT, PET/CT, X-ray, and Bone Scan

Imaging creates pictures of the inside of the body. Not everyone with penile cancer needs scans. They are added when your doctor needs to know how deep the tumor goes before planning surgery, or when there is reason to think the cancer has traveled beyond the penis. In men whose groin nodes feel normal, extra scans of the abdomen and chest are generally not recommended, because they cannot see the tiny deposits that matter at that stage.

Ultrasound uses high-frequency sound waves that bounce off tissue and return as echoes, which a computer turns into a picture called a sonogram. It is painless, uses no radiation, and takes only minutes. Gel is spread on the skin, and a small handheld probe is moved over the area. On the penis, ultrasound can help show how deeply the tumor has grown, and it is an accepted alternative when MRI is not available. In the groin, ultrasound is the standard way to look for abnormal nodes and to guide an FNA needle in the same visit. Sometimes a medicine is injected into the penis to produce a temporary erection during the scan, which spreads the tissue out and makes the boundaries easier to see.

MRI, or magnetic resonance imaging, uses a strong magnet and radio waves instead of radiation to make very detailed pictures of soft tissue. You lie still inside a tube for perhaps 30 to 45 minutes, and a contrast dye called gadolinium may be injected into a vein to sharpen the images. For penile cancer, MRI answers one question especially well: has the tumor invaded the erectile chambers? For that question, MRI correctly identifies invasion about 80% of the time and correctly rules it out about 96% of the time. That is why MRI is recommended when there is doubt about erectile chamber invasion or about whether organ-sparing surgery is possible. MRI does not beat a careful physical exam for telling apart the earliest stages. You may be offered an injection into the penis to create an artificial erection during the scan so that depth can be mapped more clearly. It is a legitimate part of the test, and nothing to be embarrassed about, and current guidelines note that an artificial erection is helpful but not mandatory, since accuracy is similar either way.

CT scan, also called a CAT scan, combines many X-ray images into cross-sectional slices of the body. Contrast dye is often injected into a vein first, so tell the team about any allergy to iodine or contrast. CT of the chest, abdomen, and pelvis is widely available and is used mainly to look for cancer in the deeper pelvic nodes, the liver, the lungs, and elsewhere. Its weakness is small nodes. CT finds cancer in pelvic nodes only about 20% to 38% of the time in penile cancer, and a pooled analysis put sensitivity at roughly 42% for CT and 39% for MRI, with specificity about 82% for both. CT can also guide a biopsy needle into a deep node.

PET/CT combines a positron emission tomography scan with a CT scan. A small amount of radioactive sugar is injected into a vein. Cancer cells are more active than normal cells, so they take up more of the sugar and light up brighter on the picture. In men with a confirmed cancerous groin node, PET/CT is the preferred way to check the pelvis and look for distant spread, with reported sensitivity of 91% and specificity of 100% for pelvic spread. In men whose groins feel normal, PET/CT is not recommended, because it does not reliably see node deposits smaller than about 10 millimeters. Fewer than 5% of men have distant spread at diagnosis, and when it does happen, it almost always comes alongside groin or pelvic node involvement.

A chest X-ray sends a small amount of radiation through the body onto a detector to make a flat image. It is a quick and simple way to check whether cancer has reached the lungs, and it may be used when a full CT of the chest is not needed. A bone scan uses a radioactive tracer that collects in bone. You are injected, wait a few hours while the tracer settles, then lie under a scanner. Areas where bone is unusually active show up as bright spots. A bone scan is not routine, but your doctor may order one if you have bone pain, an unexplained rise in blood calcium, or other signs pointing to bone involvement.

Blood Tests

Blood tests do not diagnose penile cancer. There is no blood marker that says yes or no. What blood tests do is show how your body is functioning, catch problems that need treating before surgery, and occasionally give a clue about how advanced the disease is.

A complete blood count, or CBC, measures your red blood cells, white blood cells, and platelets. It is a general health check. Low red cells (anemia) can cause fatigue and may need correcting before an operation. White cell changes can point to infection, which matters because penile tumors often become infected. Platelets affect clotting and are checked before surgery.

Blood chemistry tests measure substances in your blood that reflect how your organs are working. Liver enzymes such as ALT, AST, and alkaline phosphatase are measured to check liver function, and kidney tests are checked because kidney function affects whether you can safely receive contrast dye or certain chemotherapy drugs.

The result that gets special attention in penile cancer is serum calcium. High blood calcium, called hypercalcemia, can occur in advanced penile cancer, particularly when cancer has reached the bones. Squamous cell cancers can also release a hormone-like substance that pulls calcium out of the bones and into the blood even without bone spread. High calcium can cause thirst, frequent urination, nausea, constipation, muscle weakness, and confusion, and severe cases need urgent treatment with fluids and medicines. So an unexpectedly high calcium level is a signal to look harder for spread and to treat the calcium level itself.

It is important to keep this in perspective. An abnormal blood test on its own does not mean your cancer has spread. Many things raise or lower these numbers, from dehydration to medications you already take. Your doctor reads them alongside your exam, your pathology, and your scans, never on their own. If a result concerns your team, they will tell you what they plan to do next.

HPV and HIV Testing

HPV, human papillomavirus, is a very common virus passed through skin-to-skin sexual contact. Roughly half of penile cancers worldwide are linked to high-risk HPV types, especially HPV 16. Because of that, HPV status is now part of the standard workup, but the testing is done differently than you might expect.

HPV is checked on the tumor tissue, not with a swab or a blood test. The pathologist stains your biopsy or surgical specimen for the p16 protein, which builds up when high-risk HPV is driving the cancer. More precise molecular tests that look directly for HPV genetic material are considered desirable but are mostly used in research settings, and studies comparing them with p16 staining have found that p16 is very good at catching HPV activity while sometimes flagging tumors that are not truly HPV driven. Your report may therefore describe your cancer as HPV associated or HPV independent based on the p16 result.

Knowing your HPV status does not usually change which treatment you are offered right now. What it does is refine your outlook, since p16 positive tumors have generally shown better survival, and it helps researchers match men to the right clinical trials. It also opens a conversation about HPV vaccination for family members and partners. Learning that your cancer is HPV related is not a verdict on your character or your relationships. HPV is so common that most sexually active adults encounter it, and there is no way to know when or from whom it was acquired.

HIV, human immunodeficiency virus, comes up for a different reason. HIV weakens the immune system, which makes it harder for the body to clear HPV and easier for abnormal cells to progress. Your doctor will ask whether you have HIV or any other condition that lowers your immunity, and if your status is unknown or you have risk factors, you may be offered an HIV blood test. Guidance on cancer in people living with HIV is published by the National Comprehensive Cancer Network. Knowing your HIV status is practical rather than judgmental. It affects infection risk around surgery, how you tolerate chemotherapy or radiation, which drugs interact with each other, and how closely you need to be watched afterward. If a test is positive, HIV is highly treatable, and cancer treatment can go ahead alongside it.

What Happens After Your Test Results Come Back?

Once the biopsy and any node or imaging results are in, your care team puts them together into a stage. Staging uses the TNM system: T for how deep the tumor has grown and what structures it involves, N for whether and how many lymph nodes contain cancer, and M for whether cancer has reached distant parts of the body. Grade is folded in for some early stages. Stage 0 means abnormal cells confined to the surface layer, and stage IV means cancer has reached the pelvic nodes, broken through a node capsule, or spread to distant sites. Our guide to penile cancer stages walks through each one in plain language.

You may hear about two versions of the stage. The clinical stage is based on your exam and scans before surgery. The pathological stage is based on what the pathologist finds in the tissue that was actually removed. The two do not always match, and the pathological stage is generally the more accurate of the two. If your stage changes after surgery, that is a normal part of the process, not a mistake. Of everything in the report, lymph node status carries the most weight for predicting outcomes, which is why so much of the workup focuses on the groin. You can read more about what these numbers mean in our guide to penile cancer survival rates.

The same argument applies to where you are treated. The evidence shows that outcomes for the key staging procedure, dynamic sentinel node biopsy, are better at centers that perform it often, with fewer missed cancers than at lower volume hospitals. Guidelines explicitly call for penile cancer care to be concentrated in specialized referral centers, and several countries have built national networks to do exactly that. If you live far from such a center, one option is to travel for the staging surgery and the treatment decisions, then have follow-up care closer to home. Ask your urologist directly how many penile cancer cases the team handles each year, and whether a referral makes sense. It is a fair question and a good doctor will welcome it.

Take someone with you to the results appointment if you can. A second set of ears catches things you will not, especially when you are absorbing hard news. Ask for a copy of your pathology report and a written summary of your stage. Ask what the plan is, what the alternatives are, and what happens if you take a week to think. Our guide to questions to ask about penile cancer has a printable list you can bring with you, covering the tests you still need, the treatment options for your stage, effects on urination and sexual function, and whether a clinical trial fits your situation.

Finally, give yourself room to feel whatever you feel. Waiting for results is one of the hardest parts of this, and many men describe the workup period as more stressful than treatment itself. You do not have to handle it silently. HealthTree offers penile cancer support resources, and connecting with other men who have been through the same tests can make a real difference. Whatever your results show, the next step is a conversation with your own care team about what the findings mean for you and what you want to do next.

Sources:

• Penile Cancer Treatment (PDQ) Patient Version, National Cancer Institute

• Sentinel Lymph Node Biopsy, National Cancer Institute

• EAU Guidelines on Penile Cancer: Epidemiology, Aetiology and Pathology, European Association of Urology

• Early Detection, Diagnosis, and Staging for Penile Cancer, American Cancer Society

• Diagnosis of Penile Cancer, Canadian Cancer Society

• Discrepancy of p16 Immunohistochemical Expression and HPV RNA in Penile Cancer, PubMed Central